Ann: Ryoncil Pricing Set and Available This Quarter, page-519

great summary , thank u .

Few point Imho

This does overstates the ease of reimbursement. Just because a treatment is FDA-approved does not mean insurers will automatically cover it. STate variation are complex as well as out-of-pocket burden cannot be neglected. not every state every insurer ill give 100% coverage and aslo depends upon the patient coverage on their insurance.

12+ would have to go through the route of rux and even mutiple times before RYnocil even comes into picture

below 12 - i highly doubt that that can be refused coverage since no alternative. Large insurers like UnitedHealth, Cigna may take several months to finalize their policies, affecting early adoption which can have notable effect on the timeline for achieving sales projections.

to me, the biggest and most certain obstacle remains the insurance system—navigating through the various insurers, securing coverage, and ensuring timely reimbursement. This will likely be the biggest time-consuming and costly challenge that could significantly delay the commercial success of Ryoncil. Personally i'll be watching that space before going in with a big parcel .